Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117383) titled 'Clinical Characteristics and Inflammatory Mechanism Research of Cardiorenal Metabolic Syndrome in Patients with Primary Aldosteronism' on Jan. 23.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Army Medical Center of PLA
Condition:
primary aldosteronism
Intervention:
Patients with primary aldosteronism:NA
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-02-01
Target Sample Size: Patients with primary aldosteronism:359;Patients with essential hypertension:541;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/show...